Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …

News

Kymriah to be made available in UK for paediatric leukaemia patients via Cancer Drugs Fund

November 15, 2018
Sales and Marketing CAR-T, Cancer, Cancer Drugs Fund, Kymriah, NHS, NICE, leukaemia, pharma

NICE has announced its recommendation that Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) be made available in the treatment of relapsed …

News
eisa0001

Eisai’s Lenvima wins over NICE in liver cancer in just three months

November 9, 2018
Medical Communications, Sales and Marketing Cancer, Eisai, Lenvima, Levantinib, NHS, NICE, UK, liver cancer, pharma

Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now …

News
nice_new_london_office_internal_2_8

NICE fail to recommend AstraZeneca’s cancer drug Olaparib on cost effectiveness basis

November 9, 2018
Medical Communications, Sales and Marketing AstraZeneca, NHS, NICE, UK, olaparib, pharma

Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib …

News
jazz_pharma

Jazz Pharma’s Vyxeos secures NICE recommendation in acute myeloid leukaemia

November 8, 2018
Sales and Marketing Cancer, NHS, NICE, UK, Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, pharma

Jazz Pharmaceuticals has revealed that NICE has chosen to recommend that its 44mg/100mg powder formulation of Vyxeos for concentrate for …

News
jeanette_kusel

NICE appoints experienced pharma consultant as Director of NICE Scientific Advice

November 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, government, national institute of health and care excellence, politics, sciences

The National Institute for Health and Care Excellence (NICE) has appointed Jeanette Kusel as Director of NICE Scientific Advice. The …

Appointment
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10

Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …

News

NICE turns down Sanofi’s Caprelsa for rare thyroid cancer

October 31, 2018
Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma

NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …

News

NICE issues draft guidance rejecting Abbvie’s Venclyxto in chronic lymphocytic leukaemia

October 26, 2018
Medical Communications, Sales and Marketing AbbVie, NHS, NICE, leukaemia, pharma, venetoclax

It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health …

News
lilly_entrance_web

NICE rejects Elil Lilly’s Verzenio for breast cancer in draft guidance

October 19, 2018
Medical Communications, Sales and Marketing Eli Lilly, NICE, UK, Verzenios, breast cancer, pharma

Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that …

News

NICE recommends first new X-linked hypophosphataemia therapy in over 30 years

October 10, 2018
Research and Development, Sales and Marketing Crysvita, Kyowa Kirin International, NHS, NICE, X-linked hypophosphataemia, pharma

NICE has announced its evidence-based recommendation that Kyowa Kirin International’s Crysvita (burosumab) be made available on the NHS for the …

News
nice_new_london_office_internal_2_8

NICE guidelines on antidepressant withdrawal symptoms are misleading, study shows

October 9, 2018
Manufacturing and Production NICE, UK, addiction, antidepressants, research, study

Current NICE guidance concerning the severity of the effects of antidepressant withdrawal is misleading doctors according to research published in …

News

NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia

October 8, 2018
Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma

NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …

News
gilead_hq_at_stockley_park_london_2

NHS England appoves Gilead’s CAR T therapy Yescarta

October 5, 2018
Medical Communications Gilead, NHS, NICE, UK, Yescarta

Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive …

News
kymriah

NICE rejects CAR-T therapy Kymriah for DLBCL in adults

September 19, 2018
Research and Development CAR T, CAR-T, Kymriah, NICE, Novartis, leukaemia

The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026